Sol-Gel Technologies Ltd
NASDAQ:SLGL 3:57:03 PM EDT
Earnings Announcements
Sol-Gel Technologies Reports Second Quarter 2022 Financial Results
Published: 08/04/2022 10:21 GMT
Sol-Gel Technologies Ltd (SLGL) - Sol-gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update.
Q2 Revenue $3.5 Million Versus $900,000.
Receives $3.5 Million Milestone Payment From Commercial Partner Galderma Holding Sa ("galderma") for FDA Approval of Epsolay.
Cash Runway Expected to Extend Through End of 2023.
Qtrly Loss per Share $0.53.
Q2 Earnings per Share View $-0.10, Revenue View $4.6 Million -- Refinitiv Ibes Data (analyst estimates).
Q2 Revenue $3.5 Million Versus $900,000.
Receives $3.5 Million Milestone Payment From Commercial Partner Galderma Holding Sa ("galderma") for FDA Approval of Epsolay.
Cash Runway Expected to Extend Through End of 2023.
Qtrly Loss per Share $0.53.
Q2 Earnings per Share View $-0.10, Revenue View $4.6 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.63 Million
Adjusted EPS is expected to be -$0.10
Next Quarter Revenue Guidance is expected to be $5.85 Million
Next Quarter EPS Guidance is expected to be -$0.06
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.10
Next Quarter Revenue Guidance is expected to be $5.85 Million
Next Quarter EPS Guidance is expected to be -$0.06
More details on our Analysts Page.